| News
Roche authorized to distribute coronavirus antibody tests
04.05.2020
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Roche in Basel (img: Roche)
The US Food and Drug Administration (FDA) has approved Emergency Use Authorization for market launch of the coronavirus antibody test developed by Roche. As of Monday, this will be distributed to labs and hospitals around the world, as detailed in a press release.
“Our best scientists have worked 24/7 over the last few weeks and months to develop a highly reliable antibody test to help fight this pandemic”, comments Thomas Schinecker, CEO of Roche Diagnostics, in the press release. According to information presented by Roche in the press release, the test boasts a specificity score of 99.8% and 100% sensitivity.
Severin Schwan, CEO of the Roche Group, was also quoted in the press release, stating: “I am in particular pleased about the high specificity and sensitivity of our test, which is crucial to support health care systems around the world with a reliable tool to better manage the COVID-19 health crisis”.
Roche has already started to distribute the tests to labs and hospitals around the world. Thanks to extensive, global production capacities, Roche will be in a position to supply the tests in high double-digit million quantities from May onwards, while capacities are also to be gradually expanded as well.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Genedata expanding its user network
The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...
Read MoreHow Moderna is growing in Switzerland
The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read MoreSandoz decides on Basel for headquarters
Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read MoreVectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read More